Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies

Pharmacological Reports

Volumn 66, Issue 5, 2014, Pages 799-803

  Ciddi, Veeresham ^a   Dodda, Dilip ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Advanced glycation end products; Aldose reductase inhibition; Cataract; Diabetic nephropathy; Resveratrol

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; FIDARESTAT; RESVERATROL; IMIDAZOLIDINE DERIVATIVE; STILBENE DERIVATIVE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CATTLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; ENZYME INHIBITION; GLYCEMIC CONTROL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; MALE; NONHUMAN; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINE; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODEL; DRUG EFFECTS; IC50; KIDNEY FUNCTION TEST; LENS; PATHOLOGY; WISTAR RAT;

ALDEHYDE REDUCTASE; ANIMALS; CATARACT; CATTLE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLYCOSYLATION END PRODUCTS, ADVANCED; IMIDAZOLIDINES; INHIBITORY CONCENTRATION 50; KIDNEY FUNCTION TESTS; LENS, CRYSTALLINE; MALE; RATS; RATS, WISTAR; STILBENES; STREPTOZOCIN;

EID: 84903301296     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2014.04.006     Document Type: Article

References (30)

1. R. Sicree, J. Shaw, and P. Zimmet Diabetes and impaired glucose tolerance Diabetes atlas 2nd ed. 2006 International Diabetes Federation Belgium 15 103
2. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 6865 2001 813 820
3. J.H. Kinoshita, L.O. Merola, K. Satoh, and E. Dikmak Osmotic changes caused by the accumulation of dulcitol in the lenses of rats fed with galactose Nature 194 1962 1085 1087
4. D.A. Greene, S.A. Lattimer, and A.A. Sima Sorbitol: phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications N Engl J Med 316 10 1987 599 606
5. C. Veeresham, A. Rama Rao, and K. Asres Aldose reductase inhibitors of plant origin Phytother Res 2013 10.1002/ptr.5000
6. M.P. Joana, C.M. Helena, and J. Emilla Resveratrol A polyphenol with multiple effects Recent Adv Pharm Sci 2011 101 120
7. S. Sharma, M. Anjaneyulu, S.K. Kulkarni, and K. Chopra Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats Pharmacology 76 2 2006 69 75
8. C.C. Chang, C.Y. Chang, Y.T. Wu, J.P. Huang, T.H. Yen, and L.M. Hung Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase J Biomed Sci 18 1 2011 47
9. S. Hayman, and J.H. Kinoshita Isolation and properties of lens aldose reductase J Biol Chem 240 1965 877 882
10. O.H. Lowry, N.J. Rosebrogh, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J Biol Chem 193 1 1951 265 275
11. M.J. Cerelli, D.L. Curtis, J.P. Dunn, P.H. Nelson, T.M. Peak, and L.D. Waterbury Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids J Med Chem 29 11 1986 2347 2351
12. H.A. Jung, Y.J. Jung, N.Y. Yoon, M. Jeongda, H.J. Bae, and D.W. Kim et al. Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase: advanced glycation end products formation, and oxidative stress Food Chem Toxicol 46 12 2008 3818 3826
13. J.A. Vinson, and T.B. Howard Inhibition of protein glycation and advanced glycation end product by ascorbic acid and other vitamins and nutrients J Nutr Biochem 7 1996 659 663
14. J.S. Zigler, S.C. Qin, T. Kamiya, M.C. Krishna, Q. Cheng, and S. Tumminia et al. Tempol-H inhibits opacification of lenses in organ culture Free Radic Biol Med 35 10 2003 1194 1202
15. C.D. West, and S. Rapopoort Colorimetric method for the estimation of dulcitol Pro Social Exp Biol 70 1949 142 145
16. G.R. Hervey Determination of creatinine by Jaffe reaction Nature 171 4364 1953 1125
17. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
18. M.A. Baig, V.B. Gawali, R.R. Patil, and S.R. Naik Protective effect of herbomineral formulation (Dolabi) on early diabetic nephropathy in streptozotocin-induced diabetic rats J Nat Med 66 3 2012 500 509
19. M. Sensi, F. Pricci, G. Pugliese, M.G. De Rossi, A.F. Petrucci, and A. Cristina et al. Role of advanced glycation end-products (AGE) in late diabetic complications Diabetes Res Clin Pract 28 1 1996 9 17
20. R.T. David, B.W. Gary, and U.C. Anne Aldose reductase inhibitors and diabetic complications Pharmacol Ther 54 2 1992 151 194
21. A. Collier, and M. Small The role of the polyol pathway in diabetes mellitus Br J Hosp Med 45 1 1991 38 40
22. N. Ahmed Advanced glycation end products-role in pathology of diabetic complications Diabetes Res Clin Pract 67 1 2005 3 21
23. S.K. Srivastava, K.V. Ramana, and A. Bhatnagar Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options Endocr Rev 26 3 2005 380 392
24. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1 1976 31 41
25. S. Rudberg, B. Persson, and G. Dahlquist Increased glomerular filtration rate as a predictor of diabetic nephropathy, an 8-year prospective study Kidney Int 41 4 1992 822 828
26. T. Maack, V. Johnson, S.T. Kau, J. Figueiredo, and D. Sigulem Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review Kidney Int 16 3 1979 251 270
27. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, and F. Daussin et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α Cell 127 6 2006 1109 1122
28. J.M. Forbes, M.E. Cooper, M.D. Oldfield, and M.C. Thomas Role of advanced glycation end products in diabetic nephropathy J Am Soc Nephrol 14 5 2003 254 258
29. A.A. Alhaider, H.M. Korashy, M.M. Sayed-Ahmed, M. Mobark, H. Kfoury, and M.A. Mansour Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression Chem Biol Interact 192 3 2011 233 242
30. Y. Kuzumoto, S. Kusunoki, N. Kato, M. Kihara, and P.A. Low Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat Diabetologia 49 12 2006 3085 3093